BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 16424193)

  • 21. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
    Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
    J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More stringent conditions of plasmid DNA vaccination are required to protect grafted versus endogenous islets in nonobese diabetic mice.
    Seifarth C; Pop S; Liu B; Wong CP; Tisch R
    J Immunol; 2003 Jul; 171(1):469-76. PubMed ID: 12817032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase.
    Lieberman SM; Takaki T; Han B; Santamaria P; Serreze DV; DiLorenzo TP
    J Immunol; 2004 Dec; 173(11):6727-34. PubMed ID: 15557165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.
    Unger WW; Pinkse GG; Mulder-van der Kracht S; van der Slik AR; Kester MG; Ossendorp F; Drijfhout JW; Serreze DV; Roep BO
    Ann N Y Acad Sci; 2007 Apr; 1103():192-5. PubMed ID: 17376840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGRP and insulin vaccination induce CD8+ T cell-mediated autoimmune diabetes in the RIP-CD80GP mouse.
    Fuchs YF; Adler K; Lindner A; Karasinsky A; Wilhelm C; Weigelt M; Balke H; Förtsch K; Mortler-Hildebrandt LF; Harlan DM; Pechhold K; Ziegler AG; Bonifacio E
    Clin Exp Immunol; 2014 May; 176(2):199-206. PubMed ID: 24387268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes.
    Han B; Serra P; Yamanouchi J; Amrani A; Elliott JF; Dickie P; Dilorenzo TP; Santamaria P
    J Clin Invest; 2005 Jul; 115(7):1879-87. PubMed ID: 15937548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway.
    Gurlo T; Kawamura K; von Grafenstein H
    J Immunol; 1999 Dec; 163(11):5770-80. PubMed ID: 10570259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
    Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
    Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.
    Lieberman SM; Evans AM; Han B; Takaki T; Vinnitskaya Y; Caldwell JA; Serreze DV; Shabanowitz J; Hunt DF; Nathenson SG; Santamaria P; DiLorenzo TP
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8384-8. PubMed ID: 12815107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.
    Solomon M; Flodström-Tullberg M; Sarvetnick N
    Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.
    Anderson B; Park BJ; Verdaguer J; Amrani A; Santamaria P
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9311-6. PubMed ID: 10430939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance induction by liposomes targeting a single CD8 epitope IGRP
    Buckle I; Loaiza Naranjo JD; Bergot AS; Zhang V; Talekar M; Steptoe RJ; Thomas R; Hamilton-Williams EE
    Immunol Cell Biol; 2022 Jan; 100(1):33-48. PubMed ID: 34668580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences.
    Santamaria P; Utsugi T; Park BJ; Averill N; Kawazu S; Yoon JW
    J Immunol; 1995 Mar; 154(5):2494-503. PubMed ID: 7868915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid destruction of encapsulated islet xenografts by NOD mice is CD4-dependent and facilitated by B-cells: innate immunity and autoimmunity do not play significant roles.
    Xu BY; Yang H; Serreze DV; MacIntosh R; Yu W; Wright JR
    Transplantation; 2005 Aug; 80(3):402-9. PubMed ID: 16082337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
    Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
    J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective prediction of spontaneous but not recurrent autoimmune diabetes in the non-obese diabetic mouse.
    Trudeau JD; Chandler T; Soukhatcheva G; Verchere CB; Tan R
    Diabetologia; 2007 May; 50(5):1015-23. PubMed ID: 17334749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.